AGÕæÈ˹ٷ½

STOCK TITAN
  1. Home
  2. Sec-filings
  3. ATHE
  4. [6-K] Alterity Therapeutics Limited American Current Report (Foreign Issuer)

[6-K] Alterity Therapeutics Limited American Current Report (Foreign Issuer)

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
6-K

Filing content is currently unavailable.

Source:

Stock ATHE logo
Alterity Therapeutics Ltd

NASDAQ:ATHE

ATHE Rankings

#4968 Ranked by Market Cap
N/A Ranked by Dividends

ATHE Latest News

Sep 8, 2025
Alterity Therapeutics Raises A$20.0 million in Strategic Placement
Sep 2, 2025
Alterity Therapeutics to Present at the Biotech Showcase
Jul 30, 2025
Appendix 4C � Q4 FY25 Quarterly Cash Flow Report
Jul 28, 2025
Alterity Therapeutics Reports Positive Topline Data from Open-Label Phase 2 Clinical Trial of ATH434 in Multiple System Atrophy
Jul 24, 2025
Alterity Therapeutics Announces Publication on Novel MRI Endpoint from the bioMUSE Natural History Study

ATHE Latest SEC Filings

Sep 8, 2025
[6-K] Alterity Therapeutics Limited American Current Report (Foreign Issuer)
Sep 8, 2025
[6-K] Alterity Therapeutics Limited American Current Report (Foreign Issuer)
Sep 4, 2025
[6-K] Alterity Therapeutics Limited American Current Report (Foreign Issuer)
Sep 2, 2025
[6-K] Alterity Therapeutics Limited American Current Report (Foreign Issuer)
Sep 2, 2025
[6-K] Alterity Therapeutics Limited American Current Report (Foreign Issuer)

ATHE Stock Data

77.81M
15.34M
1.45%
0.95%
Biotechnology
Healthcare
Australia
Melbourne